[1]
“Assessment of Ocular Surface Disease Status in New Patients Initiating Anti-Glaucoma Medication: A Prospective Study”, Birat J. Health Sci., vol. 10, no. 3, pp. 60–64, Dec. 2025, doi: 10.62065/bjhs752.